Halozyme Therapeutics
HALO
#2116
Rank
NZ$12.94 B
Marketcap
$105.09
Share price
1.04%
Change (1 day)
54.47%
Change (1 year)

Halozyme Therapeutics (HALO) - Total debt

Total debt on the balance sheet as of December 2024 : NZ$2.63 Billion

According to Halozyme Therapeutics's latest financial reports the company's total debt is NZ$2.63 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Halozyme Therapeutics - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$2.37 B-0.06%
2022-12-31NZ$2.37 B84.82%
2021-12-31NZ$1.28 B133.14%
2020-12-31NZ$0.55 B-7.9%
2019-12-31NZ$0.59 B217.27%
2018-12-31NZ$0.18 B-33.87%
2017-12-31NZ$0.28 B-8.89%
2016-12-31NZ$0.31 B329.5%
2015-12-31NZ$72.81 M14.42%
2014-12-31NZ$63.63 M5.07%
2013-12-31NZ$60.56 M60.15%
2012-12-31NZ$37.81 M
2011-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$0.41 B-84.04%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$58.77 B 2,134.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$23.05 B 776.21%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$116.38 B 4,324.03%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$32.55 B 1,137.44%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$64.00 B 2,332.86%๐Ÿ‡บ๐Ÿ‡ธ USA